These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 25643370)
1. Confluent diode laser coagulation: the gold standard of therapy for retinopathy of prematurity. Prepiaková Z; Tomcíková D; Kostolná B; Gerinec A J Pediatr Ophthalmol Strabismus; 2015; 52(1):43-51. PubMed ID: 25643370 [TBL] [Abstract][Full Text] [Related]
2. [Benefit of paint diode laser coagulation in the treatment of ROP]. Tomciková D; Prepiaková Z; Kostolná B; Gerinec A Cesk Slov Oftalmol; 2011 Oct; 67(4):115-8. PubMed ID: 22299519 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity. Erol N; Gürsoy H; Sahin A; Basmak H J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371 [TBL] [Abstract][Full Text] [Related]
4. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Kim J; Kim SJ; Chang YS; Park WS Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184 [TBL] [Abstract][Full Text] [Related]
5. Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP). Wutthiworawong B; Thitiratsanont U; Saovaprut C; Subhangkasen I; Geyuraphun B; Ampornprut A; Phumongkutchai J; Tephusdinnaayuthaya S J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S15-21. PubMed ID: 22043749 [TBL] [Abstract][Full Text] [Related]
6. Confluent laser photocoagulation for the treatment of retinopathy of prematurity. Gonzalez VH; Giuliari GP; Banda RM; Guel DA; Wingard M J Pediatr Ophthalmol Strabismus; 2010; 47(2):81-5; quiz 86-7. PubMed ID: 20349899 [TBL] [Abstract][Full Text] [Related]
7. Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity. Suk KK; Berrocal AM; Murray TG; Rich R; Major JC; Hess D; Johnson RA J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-4. PubMed ID: 21175113 [TBL] [Abstract][Full Text] [Related]
8. Near confluent laser photocoagulation for the treatment of threshold retinopathy of prematurity. Rezai KA; Eliott D; Ferrone PJ; Kim RW Arch Ophthalmol; 2005 May; 123(5):621-6. PubMed ID: 15883280 [TBL] [Abstract][Full Text] [Related]
9. Treatment of type 1 retinopathy of prematurity with bevacizumab versus laser. Isaac M; Mireskandari K; Tehrani N J AAPOS; 2015 Apr; 19(2):140-4. PubMed ID: 25892041 [TBL] [Abstract][Full Text] [Related]
10. Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes. Futamura Y; Asami T; Nonobe N; Kachi S; Ito Y; Sato Y; Hayakawa M; Terasaki H Jpn J Ophthalmol; 2015 Nov; 59(6):378-88. PubMed ID: 26265249 [TBL] [Abstract][Full Text] [Related]
11. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results]. Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results. Harder BC; Schlichtenbrede FC; von Baltz S; Jendritza W; Jendritza B; Jonas JB Am J Ophthalmol; 2013 Jun; 155(6):1119-1124.e1. PubMed ID: 23490192 [TBL] [Abstract][Full Text] [Related]
13. Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity. Moran S; O'Keefe M; Hartnett C; Lanigan B; Murphy J; Donoghue V Acta Ophthalmol; 2014 Sep; 92(6):e496-7. PubMed ID: 24428792 [No Abstract] [Full Text] [Related]
14. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Axer-Siegel R; Maharshak I; Snir M; Friling R; Ehrlich R; Sherf I; Shalev B; Sirota L; Weinberger D Retina; 2008 Jun; 28(6):839-46. PubMed ID: 18536600 [TBL] [Abstract][Full Text] [Related]
15. Outcome of zone 1 retinopathy of prematurity. O'Keefe M; Lanigan B; Long VW Acta Ophthalmol Scand; 2003 Dec; 81(6):614-6. PubMed ID: 14641264 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings. Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity. Axer-Siegel R; Snir M; Ron Y; Friling R; Sirota L; Weinberger D Retina; 2011; 31(7):1239-47. PubMed ID: 21555969 [TBL] [Abstract][Full Text] [Related]
18. Vitrectomy after intravitreal bevacizumab (Avastin) for retinal detachment in retinopathy of prematurity. Kychenthal A; Dorta P Retina; 2010 Apr; 30(4 Suppl):S32-6. PubMed ID: 20224474 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II. Autrata R; Krejcírová I; Senková K; Holoušová M; Doležel Z; Borek I Eur J Ophthalmol; 2012; 22(5):687-94. PubMed ID: 22669848 [TBL] [Abstract][Full Text] [Related]
20. External subretinal drainage, bevacizumab, and scleral buckling for complete exudative retinal detachment after photocoagulation in retinopathy of prematurity. Armada-Maresca F; Peralta-Calvo J; Pastora-Salvador N; Grabowska A; Vallejo-Garcia J Retin Cases Brief Rep; 2014; 8(1):33-6. PubMed ID: 25372204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]